See the DrugPatentWatch profile for keytruda

Keytruda, a cancer treatment drug manufactured by Merck & Co., is a type of immunotherapy that helps the body's immune system identify and fight cancer cells. When comparing Keytruda's cost to other treatments, it is important to consider both the list price and the actual cost to patients, as these can vary significantly due to factors such as insurance coverage and negotiated discounts.

According to DrugPatentWatch.com, Keytruda's list price is approximately $13,500 per month, or around $162,000 per year [1]. However, the actual cost to patients can be lower due to various factors, such as insurance coverage and negotiated discounts.

For comparison, other cancer treatments such as chemotherapy and radiation therapy can have varying costs depending on the type and stage of cancer, as well as the specific treatment regimen. For example, the Leukemia & Lymphoma Society estimates that the average cost of chemotherapy for chronic lymphocytic leukemia (CLL) can range from $30,000 to $100,000 per year [2]. However, it is important to note that these costs can vary widely depending on the specific drugs and treatment regimens used.

Another factor to consider when comparing the cost of Keytruda to other treatments is its effectiveness. Keytruda has been shown to be effective in treating a variety of cancers, including melanoma, lung cancer, and Hodgkin lymphoma [3]. In some cases, Keytruda has been shown to be more effective than other treatments, which may justify its higher cost.

Overall, while Keytruda's list price is higher than some other cancer treatments, the actual cost to patients can vary widely depending on a variety of factors. Additionally, Keytruda's effectiveness in treating certain types of cancer may justify its higher cost in some cases.

Sources:

1. DrugPatentWatch.com, "Keytruda (pembrolizumab)". <https://www.drugpatentwatch.com/drugs/keytruda>.
2. Leukemia & Lymphoma Society, "Treatment Costs". <https://www.lls.org/treatment/financial-support/treatment-costs>.
3. National Cancer Institute, "Keytruda". <https://www.cancer.gov/about-cancer/treatment/drugs/keytruda>.